purpos
assess
util
influenzalik
ill
ili
whether
appropri
test
influenza
vaccin
effect
princip
result
cdc
definit
influenzalik
ill
similar
howev
mani
studi
use
definit
specifi
temperatur
requir
specif
respiratori
andor
system
symptom
make
mani
sampl
noncompar
ili
studi
find
less
case
rtpcrposit
test
virus
bacteria
usual
find
multipl
pathogen
identifi
pathogen
case
ili
symptom
symptom
combin
high
sensit
specif
identifi
pcrposit
influenza
case
rapid
influenza
diagnost
test
increasingli
use
screen
ili
case
low
sensit
high
specif
compar
rtpcr
identifi
influenza
main
conclus
work
diagnosi
ili
presum
influenza
may
involv
proven
otherwis
health
care
worker
would
benefit
renam
cdc
ili
symptom
sign
acut
respiratori
ill
also
use
acut
sever
respiratori
ill
definit
ill
sever
meet
criterion
renam
would
shift
attent
identifi
viral
bacteri
pathogen
case
epidem
identifi
new
pathogen
implement
vaccin
plan
appropri
identifi
pathogen
estim
workload
viral
season
randomis
control
trial
test
effect
influenza
vaccin
requir
particip
assess
gold
standard
rtpcr
ili
role
measur
influenza
vaccin
effect
ili
well
establish
literatur
oper
definit
mani
surveil
databas
imprecis
definit
may
inhibit
progress
research
treatment
current
ili
definit
could
benefit
renam
acut
respiratori
ill
addit
definit
sever
acut
respiratori
ill
sari
rtpcr
test
pathogen
facilit
prevent
treatment
also
vari
time
french
nationwid
sentinel
system
report
ili
case
influenza
epidem
found
predomin
seven
epidem
isol
four
b
two
assess
whether
influenzalik
ill
use
concept
appropri
test
influenza
vaccin
effect
medlin
embas
cochran
librari
search
incept
decemb
influenzalik
ill
ili
http
dx
million
death
children
year
million
estim
due
ili
incid
similar
higher
lower
incom
countri
mortal
rate
higher
lower
incom
countri
sever
acut
respiratori
ill
sari
import
caus
death
among
children
lowincom
countri
definit
ili
plu
cough
sore
throat
plu
measur
fever
short
breath
need
hospit
pathogen
detect
ili
case
vari
wide
limit
number
ili
studi
test
multipl
virus
bacteria
found
percentag
influenza
usual
rang
b
pathogen
found
tabl
pathogen
cdc
defin
ili
temperatur
f
c
oral
equival
cough
sore
throat
absenc
known
caus
influenza
defin
ili
similarli
sudden
onset
fever
c
cough
sore
throat
absenc
diagnos
sever
acut
respiratori
ill
sari
ili
plu
short
breath
andor
difficulti
breath
hospit
admiss
mani
studi
use
ili
definit
specifi
fever
combin
respiratori
constitut
symptom
supplement
tabl
supplementari
materi
relat
articl
found
onlin
version
http
cochran
review
effect
influenza
vaccin
found
mark
differ
rel
risk
laboratoryproven
influenza
ili
age
group
children
year
healthi
adult
adult
nurs
home
adult
commun
impli
laboratoryproven
influenza
ili
measur
differ
ill
supplement
tabl
supplementari
materi
relat
articl
found
onlin
version
http
limit
number
studi
ili
includ
belgium
franc
netherland
portug
europ
canada
mexico
us
one
studi
el
salvador
hondura
nicaragua
america
china
india
vietnam
asia
studi
african
countri
vari
use
cdc
definit
tabl
two
us
retrospect
studi
patient
seen
acut
respiratori
problem
us
emerg
depart
test
respiratori
virus
rtpcr
met
cdc
ili
definit
posit
sensit
cdc
ili
definit
specif
cdc
definit
exclud
proven
caus
patient
test
four
common
altern
diagnos
chest
xray
posit
acut
bacteri
pneumonia
posit
rapid
rsv
antigen
rapid
streptococc
throat
cultur
posit
mononucleosi
spot
test
sensit
cdc
definit
increas
specif
declin
two
studi
china
peke
univers
peopl
hospit
patient
year
fever
outpati
servic
screen
ili
test
rtpcr
posit
influenza
influenza
b
rhinovirus
adenoviru
coronavirus
rsv
multipl
virus
studi
assess
whether
china
nation
ili
sentinel
surveil
system
sentinel
hospit
across
china
hospit
could
identifi
new
strain
laboratori
system
report
case
five
first
identifi
sentinel
system
tabl
four
studi
asia
india
train
investig
assess
patient
admit
hospit
two
year
ili
case
year
year
influenza
pcr
posit
influenza
b
children
year
sari
definit
low
sensit
high
specif
short
breath
omit
sensit
increas
specif
decreas
report
fever
allow
sensit
increas
specif
decreas
cough
ad
sensit
decreas
specif
increas
studi
epidem
singapor
juneoctob
found
pair
sampl
ili
case
yield
influenza
estim
bayesian
ci
averag
baselin
final
sampl
rate
bci
studi
vietnam
site
nation
influenza
sentinel
system
identifi
ili
case
influenza
b
peak
five
year
period
studi
african
countri
report
ili
case
test
rtpcr
posit
influenza
rang
angola
madagascar
low
adult
consult
rate
thu
studi
cdc
ili
definit
wide
rang
virus
bacteria
influenza
rate
usual
three
studi
europ
belgian
network
screen
respiratori
ill
pandem
nasopharyng
sampl
test
rtpcr
adult
test
posit
influenza
children
influenza
b
rhinoviru
rsv
picornaviru
metapneumoviru
ili
patient
two
french
univers
hospit
earli
epidem
test
rtpcr
multiplex
assay
posit
rhinovirus
influenza
parainfluenza
virus
mix
viral
infect
adenovirus
coronavirus
rsv
bacteria
amsterdam
studi
ili
patient
found
influenza
rhinoviru
parainfluenza
viru
coronavirus
metapneumovirus
virus
specifi
two
studi
america
ili
outpati
five
health
centr
el
salvador
hondura
nicaragua
test
rtpcr
influenza
identifi
ili
case
influenza
b
rsv
adenovirus
picornavirus
metapneumovirus
mexico
citi
five
hospit
ili
patient
test
rtpcr
influenza
influenza
b
rhinoviru
coronaviru
rsv
metapneumoviru
parainfluenzaviru
mix
viral
infect
three
studi
asia
outpati
zhuhai
cdc
china
ili
definit
refer
thu
studi
use
cdc
ili
definit
pcrposit
rate
influenza
usual
use
ili
symptom
predict
cultur
rtpcr
posit
influenza
difficult
symptom
occur
influenza
infect
asymptomat
infect
person
shed
detect
influenza
viru
may
transmit
influenza
other
although
data
support
frequenc
transmiss
prior
symptom
limit
instanc
individu
case
influenza
difficult
identifi
reliabl
clinic
examin
routin
clinic
laboratori
find
alon
appropri
use
influenza
diagnost
test
help
ili
caus
viral
speci
patient
exhibit
wide
overlap
symptom
render
clinic
diagnosi
unreli
ili
patient
tend
rate
three
key
ili
symptom
fever
cough
sore
throat
sever
studi
report
symptom
level
tabl
could
due
differ
ill
patient
question
health
care
profession
marseil
pandem
studi
demonstr
remark
similar
influenza
human
rhinoviru
symptom
ili
symptom
case
hrv
similar
percentag
symptom
studi
assess
symptom
show
wide
rang
variat
tabl
sever
studi
assess
symptom
predict
posit
laboratori
test
influenza
schnepf
studi
french
ili
patient
found
patient
viru
detect
less
like
cough
p
like
pharyng
compar
p
schnepf
abl
predict
pcrposit
hutterit
coloni
studi
found
combin
fever
cough
sore
throat
muscl
ach
predict
pcr
influenza
posit
confid
interv
wide
indian
council
medic
research
influenza
surveil
network
studi
found
three
symptom
correl
influenza
pcrposit
cough
p
fatigu
p
chillsrigour
p
sari
also
wide
variat
symptom
bodi
ach
correl
influenza
pcrposit
belgian
gener
practition
network
ili
studi
enquir
symptom
report
fever
note
frequent
symptom
confirm
influenza
similar
rsv
portugues
studi
found
fever
c
correl
laboratoryproven
influenza
san
diego
militari
studi
found
acut
onset
day
c
cough
bodi
ach
correl
p
pcr
proven
influenza
australia
differ
definit
use
two
state
differ
definit
two
year
western
australia
combin
cough
fever
fatigu
myalgia
sensit
rang
specif
cough
fever
sensit
rang
specif
systemat
review
identifi
seven
studi
influenza
symptom
symptom
sign
summari
likelihood
ratio
high
cough
nasal
congest
fever
sign
likelihood
ratio
decreas
likelihood
influenza
studi
amsterdam
patient
use
netherland
medic
assist
accid
disast
ili
definit
test
rtpcr
cdc
uk
health
protect
agenc
ili
definit
also
test
averag
sensit
specif
author
conclud
four
case
definit
seem
compar
rather
useless
review
studi
found
sensit
clinic
diagnosi
compar
viral
cultur
rtpcr
specif
studi
show
mark
heterogen
ili
case
thu
show
wide
variat
symptom
frequenc
although
fever
cough
correl
posit
pcrproven
influenza
mani
studi
ceil
effect
fever
cough
often
even
predict
valu
strong
enough
reli
discrimin
pcr
neg
case
symptom
symptom
combin
vari
studi
provid
statist
stabl
pattern
predict
ili
patient
influenza
pathogen
sever
factor
improv
diagnost
test
accuraci
nasopharyng
aspir
wash
follow
nasopharyng
swab
midturbin
swab
nostril
provid
higher
yield
throat
swab
flock
swab
releas
sampl
transport
media
better
mattress
swab
sampl
obtain
within
day
symptom
onset
provid
higher
yield
first
h
rtpcr
sensit
cultur
requir
infecti
viru
remain
posit
longer
transport
result
experienc
laboratori
monitor
test
perform
better
rapid
influenza
diagnost
test
ridt
increasingli
use
ili
screen
sixteen
studi
quickvu
rapid
flu
test
found
mark
heterogen
compar
viral
cultur
rtpcr
randomeffect
sensit
specif
studi
patient
six
us
state
found
quidel
quickvu
b
test
sensit
specif
compar
rtpcr
metaanalysi
studi
pandem
ridt
found
mani
methodolog
defect
defin
recruit
criteria
blind
provid
inform
symptom
durat
ridt
compar
rtpcr
studi
viral
cultur
rtpcr
sensit
cultur
ridt
pool
sensit
compar
rtpcr
lower
compar
viral
cultur
ridt
specif
high
compar
rtpcr
compar
viral
cultur
sensit
higher
children
adult
higher
viral
load
shed
longer
sensit
also
higher
influenza
compar
influenza
b
headtohead
comparison
ridt
directigen
flu
highest
pool
sensit
statist
better
next
best
test
quickvu
influenza
test
directigen
flu
b
p
quickvu
influenza
b
p
binaxnow
p
statist
inferior
ridt
combin
seven
fdaapprov
ridt
test
abil
detect
variant
influenza
virus
detect
season
six
seven
detect
four
detect
v
virus
differ
concentr
thu
ridt
high
specif
variabl
modest
sensit
use
assess
effect
influenza
vaccin
inaccuraci
introduc
australian
flutrack
programm
commun
member
record
symptom
onlin
statement
survey
question
report
fever
cough
defin
ili
minim
correl
nation
laboratori
influenza
notif
studi
influenza
activ
hong
kong
januari
exclud
subsequ
pandem
defin
ili
plu
cough
andor
sore
throat
found
diagnos
gp
ili
correl
outpati
clinic
correl
influenza
rate
sampl
report
public
laboratori
data
provid
number
case
test
pathogen
author
comment
laboratori
data
alon
suffer
denomin
dilut
period
noninfluenza
epidem
gp
ili
data
alon
suffer
numer
dilut
ili
episod
associ
influenza
influenzalik
ill
broad
definit
rtpcr
viral
cultur
test
show
mani
ili
studi
fewer
patient
influenza
mani
virus
bacteria
found
pathogen
identifi
major
patient
thu
hear
influenza
pathogen
ili
definit
may
caus
inappropri
certainti
public
politician
decisionmak
health
profession
influenza
caus
far
acut
respiratori
ill
true
use
ili
concept
reduc
focu
public
health
profession
attent
proven
measur
reduc
transmiss
acut
respiratori
pathogen
influenza
vaccin
antivir
medic
effect
virus
pathogen
involv
acut
respiratori
ill
divers
societ
medic
financi
resourc
away
interrupt
transmiss
cycl
pathogen
suggest
patient
health
care
worker
organis
funder
anticip
influenza
pandem
prevent
influenza
vaccin
treatment
influenzaspecif
antivir
key
activ
health
system
attent
also
need
given
detect
pathogen
circul
use
proven
barrier
hygien
method
prevent
transmiss
mani
pathogen
possibl
would
also
reduc
overal
workload
medic
system
health
offici
would
benefit
renam
symptom
sign
label
ili
acut
respiratori
ill
use
definit
sever
acut
respiratori
ill
sari
cough
sore
throat
plu
measur
fever
short
breath
hospitalis
area
without
hospit
need
hospitalis
could
serv
descriptor
sever
renam
would
focu
fund
identif
viral
bacteri
epidem
randomis
control
trial
test
effect
influenza
vaccin
requir
particip
assess
gold
standard
rtpcr
follow
patient
long
enough
measur
influenzaspecif
mortal
ili
role
measur
influenza
vaccin
effect
ili
well
establish
literatur
oper
definit
mani
surveil
databas
howev
would
tuberculosi
specialist
accept
definit
includ
mani
unrel
pathogen
imprecis
definit
inhibit
progress
research
treatment
ili
ad
list
recommend
contradict
medic
practic
stop
use
renam
